Cargando…

A fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment

An updated version of FATEMOD, a multimedia fugacity model for environmental fate of organic chemicals, was set up to assess environmental behaviour of three pharmaceuticals in northern Lake Päijänne, Finland. Concentrations of ibuprofen, diclofenac, and carbamazepine were estimated at various depth...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurmi, Tuomas M. A., Kiljunen, Toni K., Knuutinen, Juha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318256/
https://www.ncbi.nlm.nih.gov/pubmed/30397752
http://dx.doi.org/10.1007/s11356-018-3485-x
_version_ 1783384840621522944
author Nurmi, Tuomas M. A.
Kiljunen, Toni K.
Knuutinen, Juha S.
author_facet Nurmi, Tuomas M. A.
Kiljunen, Toni K.
Knuutinen, Juha S.
author_sort Nurmi, Tuomas M. A.
collection PubMed
description An updated version of FATEMOD, a multimedia fugacity model for environmental fate of organic chemicals, was set up to assess environmental behaviour of three pharmaceuticals in northern Lake Päijänne, Finland. Concentrations of ibuprofen, diclofenac, and carbamazepine were estimated at various depths at two sites: near a wastewater treatment plant and 3.5 km downstream the plant. When compared with environmental sampling data from corresponding depths and sites, the predicted concentrations, ranging from nanograms to hundreds of nanograms per litre, were found to be in good agreement. Weather data were utilised with the model to rationalise the effects of various environmental parameters on the sampling results, and, e.g. the roles of various properties of lake dynamics and photodegradation were identified. The new model also enables simultaneous assessment of transformation products. Environmentally formed transformation product concentrations were estimated to be at highest an order of magnitude lower than those of the parent compounds, and unlikely to reach a detectable level. However, a possibility that conjugates of ibuprofen are present at higher levels than the parent compound was identified. Simulation results suggest that environmental degradation half-lives of the inspected contaminants under stratified lake conditions are in the range of some weeks to months.
format Online
Article
Text
id pubmed-6318256
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63182562019-01-14 A fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment Nurmi, Tuomas M. A. Kiljunen, Toni K. Knuutinen, Juha S. Environ Sci Pollut Res Int Research Article An updated version of FATEMOD, a multimedia fugacity model for environmental fate of organic chemicals, was set up to assess environmental behaviour of three pharmaceuticals in northern Lake Päijänne, Finland. Concentrations of ibuprofen, diclofenac, and carbamazepine were estimated at various depths at two sites: near a wastewater treatment plant and 3.5 km downstream the plant. When compared with environmental sampling data from corresponding depths and sites, the predicted concentrations, ranging from nanograms to hundreds of nanograms per litre, were found to be in good agreement. Weather data were utilised with the model to rationalise the effects of various environmental parameters on the sampling results, and, e.g. the roles of various properties of lake dynamics and photodegradation were identified. The new model also enables simultaneous assessment of transformation products. Environmentally formed transformation product concentrations were estimated to be at highest an order of magnitude lower than those of the parent compounds, and unlikely to reach a detectable level. However, a possibility that conjugates of ibuprofen are present at higher levels than the parent compound was identified. Simulation results suggest that environmental degradation half-lives of the inspected contaminants under stratified lake conditions are in the range of some weeks to months. Springer Berlin Heidelberg 2018-11-05 2019 /pmc/articles/PMC6318256/ /pubmed/30397752 http://dx.doi.org/10.1007/s11356-018-3485-x Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Article
Nurmi, Tuomas M. A.
Kiljunen, Toni K.
Knuutinen, Juha S.
A fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment
title A fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment
title_full A fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment
title_fullStr A fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment
title_full_unstemmed A fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment
title_short A fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment
title_sort fugacity model assessment of ibuprofen, diclofenac, carbamazepine, and their transformation product concentrations in an aquatic environment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318256/
https://www.ncbi.nlm.nih.gov/pubmed/30397752
http://dx.doi.org/10.1007/s11356-018-3485-x
work_keys_str_mv AT nurmituomasma afugacitymodelassessmentofibuprofendiclofenaccarbamazepineandtheirtransformationproductconcentrationsinanaquaticenvironment
AT kiljunentonik afugacitymodelassessmentofibuprofendiclofenaccarbamazepineandtheirtransformationproductconcentrationsinanaquaticenvironment
AT knuutinenjuhas afugacitymodelassessmentofibuprofendiclofenaccarbamazepineandtheirtransformationproductconcentrationsinanaquaticenvironment
AT nurmituomasma fugacitymodelassessmentofibuprofendiclofenaccarbamazepineandtheirtransformationproductconcentrationsinanaquaticenvironment
AT kiljunentonik fugacitymodelassessmentofibuprofendiclofenaccarbamazepineandtheirtransformationproductconcentrationsinanaquaticenvironment
AT knuutinenjuhas fugacitymodelassessmentofibuprofendiclofenaccarbamazepineandtheirtransformationproductconcentrationsinanaquaticenvironment